Description: Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Home Page: acceleratediagnostics.com
0H8E Technical Analysis
3950 South Country Club Road
Tucson,
AZ
85714
United States
Phone:
520 365 3100
Officers
| Name | Title |
|---|---|
| Mr. Jack Phillips | CEO, President & Director |
| Mr. David Patience | Chief Financial Officer |
| Mr. Lawrence Michael Mertz | Chief Technology Officer |
| Ms. Maya Gowri | Senior VP & Head of Operations |
| Mr. John Meduri | Chief Strategy Officer |
| Mr. Chris Thode | Senior Vice President of US Commercial |
| Ms. Rita Boukamel | Senior VP & Head of EMEA |
Exchange: LSE
Country: GB : United Kingdom of Great Britain and Northern Ireland
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 9.0529 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 134 |